Managing diabetes and its complications can be challenging, but new approaches in regenerative medicine are providing options worth exploring. At Stemedix, we offer personalized therapies that focus on supporting your body’s natural repair mechanisms. One area of growing interest is the use of MSC-derived exosomes in stem cell treatments. These tiny cellular messengers can influence how cells communicate and respond to damage, potentially benefiting those living with diabetes.
Our team works directly with your existing medical records to design therapies tailored to your condition, including specialized protocols for nerve-related complications. For individuals dealing with neuropathy, our programs incorporate stem cell therapy for diabetic neuropathy, which aims to support nerve function and improve quality of life. Through our patient-centered approach, we provide access to advanced regenerative medicine solutions for diabetes while offering guidance and care throughout your treatment journey.
The Role of MSC-Derived Exosomes in Regenerative Medicine
Cells in your body are constantly communicating to maintain balance and respond to stress, injury, or disease. Some cells release specific signals that influence how surrounding tissues react, and this process can be especially important for conditions like diabetes. By understanding these natural communication pathways, therapies can be designed to support tissue repair and improve overall cellular function.
What Are Mesenchymal Stem Cells (MSCs)?
Mesenchymal stem cells are multipotent cells capable of developing into multiple tissue types. These cells are often collected from bone marrow, adipose tissue, or umbilical cord tissue. One of the key features of MSCs is their ability to produce factors that support tissue repair and regeneration. Among these factors are exosomes, small vesicles that carry proteins, lipids, and genetic material. These exosomes interact with nearby cells, helping them respond to stress or damage.
In therapies aimed at metabolic conditions, including stem cell therapy for diabetes, MSCs provide foundational support for regenerative processes. They create an environment in which cells can recover more effectively and function with improved coordination. This cellular-level support is a critical component of patient-centered regenerative care.
How Exosomes Support Cellular Communication and Repair
Exosomes are tiny vesicles that transmit signals between cells. They carry instructions that guide how cells respond to inflammation and tissue stress. By facilitating communication among cells, exosomes help coordinate repair and maintain tissue health. In the context of regenerative therapy, exosomes are one of the primary ways stem cell treatment for diabetes may deliver its benefits. They work directly at the cellular level, helping tissues adapt and recover in response to challenges posed by metabolic disease.
At Stemedix, we focus on leveraging MSCs and their exosomes to develop personalized therapy plans tailored to your medical profile. This approach allows us to address specific concerns, including nerve-related complications, through stem cell therapy for diabetic neuropathy, while providing care designed to support overall tissue function and wellness.
Exploring the Connection Between Exosomes and Diabetes Care
Diabetes affects many aspects of how your body functions at the cellular level. Understanding these changes helps you see how regenerative therapies can provide supportive benefits and contribute to the overall management of the condition. By examining the cellular effects, it becomes clearer why therapies such as MSC-derived exosome treatments are being explored for patients living with diabetes.
The Impact of Diabetes on Cellular Function
Diabetes interferes with the body’s ability to manage blood sugar and maintain healthy cellular function. When blood glucose levels remain high over time, the cells that produce insulin may struggle to work efficiently. Blood vessel health can be compromised, and nerve function may decline, leading to symptoms such as tingling, numbness, pain, and slower wound healing. Fatigue often occurs because your cells are not receiving energy efficiently. These effects create a complex environment in your body, affecting multiple systems simultaneously. Interventions such as stem cell therapy for diabetic neuropathy aim to provide targeted support to nerve tissue and improve cellular communication, helping cells respond more effectively to stress and injury.
How MSC-Derived Exosomes May Support Pancreatic Health and Insulin Response
MSC-derived exosomes may help support pancreatic cell function and reduce inflammation. These microscopic vesicles carry proteins, lipids, and genetic material that act as messages between cells. A study demonstrated that MSC-derived exosomes improved pancreatic islet viability and enhanced insulin secretion in diabetic models by modulating inflammatory pathways and promoting cellular repair. By delivering these signals, exosomes can improve tissue conditions and promote healthier communication among cells. This activity may help pancreatic cells respond more effectively to challenges, supporting insulin production and better regulation of blood sugar. This biological signaling is an important component of stem cell solutions for diabetes and therapies designed to support long-term management of the condition, offering patients potential relief from complications related to both glucose control and nerve health.
Stem Cell Therapy for Diabetes: A Closer Look
Stem cell therapy offers a way to explore additional support for your body’s natural repair processes. By focusing on regenerative signals, this therapy aims to complement the care you already receive for diabetes.
Regenerative Mechanisms and Potential Benefits
Stem cell therapy supports the body’s natural repair mechanisms. The treatment uses MSC-derived products that interact with cells to help regulate communication and promote tissue balance. You may notice improvements in energy levels or faster recovery from wounds. Some patients also report a reduction in neuropathic discomfort, which can make daily activities more manageable. While responses differ from person to person, these therapies are grouped under stem cell treatment for diabetes, offering options for those seeking additional support in managing their condition.
At Stemedix, our approach focuses on reviewing your existing medical records and developing a personalized therapy plan tailored to your needs, helping you explore regenerative treatments safely and with guidance from experienced providers.
Stem Cell Therapy for Diabetic Neuropathy
Stem cell therapy may help manage nerve-related symptoms associated with diabetes. Exosomes, released by MSCs, carry signals that can support damaged nerve tissue and improve cellular communication. Clinical studies have shown that stem cell therapy can significantly improve nerve conduction and sensory function in diabetic neuropathy patients, supporting its potential to maintain nerve function and reduce discomfort. If you experience numbness, tingling, or weakness in your extremities, this therapy may help maintain nerve function and reduce discomfort.
Through careful evaluation and personalized care, we provide access to stem cell therapy for diabetic neuropathy, helping patients address nerve complications while maintaining a focus on comfort and practical support throughout the treatment journey.
The Stemedix Approach to Personalized Regenerative Medicine
Personalized care is at the heart of effective regenerative therapy. Each treatment plan is built around your medical history and individual needs, allowing you to feel supported throughout the process.
Individualized Treatment Design Based on Existing Medical Records
We customize treatments using patients’ existing medical documentation. You provide your current medical records, such as bloodwork, imaging studies, and MRI reports, and the team carefully reviews them to determine which therapy options may be appropriate. If any of your records are outdated, we can help gather updated information by coordinating with your healthcare providers through a signed medical release. This process allows you to move forward with a plan that reflects your specific health status. Board-certified providers then create a therapy plan designed around your needs, offering a tailored approach to stem cell therapy for diabetes and related conditions.
A Full-Service Experience in Saint Petersburg, FL
We provide support services throughout treatment to keep patients comfortable. From arranging transportation and hotel accommodations to providing mobility aids like wheelchairs or walkers, the team works to make your visit as smooth as possible. A dedicated Care Coordinator stays with you through every step, offering guidance and assistance so you always know what to expect. This attentive support extends to therapies for stem cell solutions for diabetes, giving you a coordinated and patient-focused experience.
Advancing Patient Care Through Responsible Innovation
Progress in regenerative medicine is built on careful study and patient-centered practice. You can explore therapies that use MSC-derived exosomes while being confident that your care follows ethical standards and current scientific guidance.
Research and Clinical Ethics in Regenerative Medicine
Regenerative medicine at Stemedix is conducted under strict ethical and safety standards. MSC-derived exosome therapies are considered experimental and are not approved by the FDA. This means you are participating in treatments that are still being studied, with ongoing clinical data shaping their development. Each step in the process is designed to protect your well-being while exploring potential benefits. Our approach prioritizes transparency, and you will receive clear explanations of how these therapies could work and what they aim to support in your health journey. The team evaluates research findings carefully, balancing innovation with safety so you can consider these options confidently.
What Patients Can Expect from a Stemedix Consultation
Consultations involve reviewing eligibility and therapy options based on existing records. You will provide your current medical documentation, such as lab work, imaging, or MRI results. We do not diagnose conditions or conduct physical examinations, but your records are carefully reviewed by board-certified providers who determine which therapies may be suitable for your condition. The team explains potential outcomes and walks you through each step of the treatment process. Patients exploring stem cell treatment for diabetes receive dedicated guidance and support, so they know exactly what to expect.
Begin Your Journey with Stemedix
If you are exploring stem cell solutions for diabetes, Stemedix is ready to guide you through every step of the process. Contact our team in Saint Petersburg, FL, to discuss your medical records and learn about personalized treatment options. Reach us by phone at (727) 456-8968 or email yourjourney@stemedix.com to start your consultation and receive dedicated support from our experienced Care Coordinators and board-certified providers.
Living with diabetes can present daily challenges, from managing blood sugar levels to coping with fatigue, nerve discomfort, and slow-healing wounds. At Stemedix, we focus on offering advanced regenerative medicine solutions designed to support your body’s natural healing processes. Our personalized stem cell treatments are tailored to your unique medical history, helping you address issues like energy depletion, neuropathy, and wound recovery.
If you are seeking regenerative care, our team provides attentive guidance and patient-focused support for every step of the process. With stem cell therapy in Saint Petersburg, FL, you gain access to a full-service experience that combines medical expertise with practical support, including travel coordination, accommodations, and accessibility services. By partnering with us, you can explore a personalized path toward managing your diabetes and improving overall wellness, guided by certified providers who design treatment plans specifically for your needs.
The Growing Challenge of Diabetes Management
Living with diabetes can be exhausting, and the daily demands of managing blood sugar, diet, and activity can feel overwhelming. Many people are looking for ways to support their overall health while managing the effects of this condition.
Diabetes and Its Long-Term Effects
Diabetes affects how the body converts food into energy. Over time, consistently high blood sugar levels can harm nerves, blood vessels, eyes, and kidneys. You may notice fatigue that limits your daily activities, wounds that heal slowly, or tingling and discomfort in your hands or feet caused by nerve damage. These challenges can make even routine tasks feel difficult, and they often accumulate over the years, affecting your overall quality of life.
According to the CDC, more than 38 million Americans have diabetes. Managing this condition involves daily monitoring, following a balanced diet, and regular medical care to track changes and prevent complications. Many people also explore stem cell treatments to support their body’s natural ability to recover and complement their existing care plans.
The Ongoing Need for Advanced Care Options
Traditional diabetes management can be complex and demanding. While medications and insulin are essential for controlling blood sugar, you might be seeking additional ways to support your health and maintain energy levels.
Emerging options in stem cell therapy offer potential benefits for supporting cellular repair and regeneration. For individuals seeking stem cell therapy in Saint Petersburg, FL, personalized programs are available that consider your specific medical history and health goals. At Stemedix, these programs combine clinical expertise with a patient-focused approach to guide you through the treatment process while addressing your individual needs.
What Is Stem Cell Therapy?
Stem cell therapy offers a new perspective on how the body can recover from certain conditions. It works with your own biology to support natural repair mechanisms rather than introducing unrelated interventions.
A Closer Look at Regenerative Medicine
Stem cell therapy is a form of regenerative medicine that focuses on the body’s ability to repair itself. Stem cells have the ability to develop into different types of cells, helping the body replace or repair damaged tissues. They also release biological factors that communicate with surrounding cells, supporting processes like inflammation reduction and tissue recovery.
These treatments interact with your body’s natural systems, working alongside your cells rather than overriding them. By doing this, they may help address complications that arise from chronic conditions such as diabetes. This process allows your body to respond in ways that could complement ongoing care and support overall well-being.
How Stem Cell Treatments Work with the Body’s Natural Healing Processes
Stem cell treatments work by supporting the body’s healing and recovery systems. Once introduced into the body, these cells release signals that stimulate tissue repair and help affected areas function more effectively.
Stem cell therapy can influence processes related to blood sugar regulation, nerve health, and energy levels. This effect may help patients manage symptoms linked to diabetes, offering an additional approach to support their health.
The Role of Stem Cell Therapy in Diabetes Care
Managing diabetes can feel like a daily balancing act. You are constantly monitoring your blood sugar, coping with fatigue, and trying to stay active, all while preventing long-term complications. Stem cell therapy offers an approach designed to support your body’s natural systems in addressing some of these challenges.
Supporting the Body’s Ability to Regulate Blood Sugar
Stem cell therapy focuses on supporting biological systems that help maintain metabolic stability. Many patients have noticed improvements in energy levels, better blood sugar management, and an overall increase in wellness after undergoing stem cell treatments. These therapies work by interacting with the body’s cells to support repair and regenerative processes, which can complement your existing diabetes care routine.
Every individual responds differently. Some people may see improvements in energy or blood sugar patterns within weeks, while others may notice gradual changes over a few months. Your medical history, age, and condition all play a role in how your body reacts to therapy, which is why personal evaluation is essential.
Helping Address Nerve Pain, Wound Healing, and Energy Levels
Patients often report reduced nerve discomfort, improved wound healing, and higher energy after therapy. For example, if you experience tingling or burning sensations from diabetic neuropathy, these symptoms may decrease. You may also notice that minor wounds heal faster, and daily fatigue feels less limiting, allowing you to stay active and engaged in your normal routine.
These effects are linked to the therapy’s potential to reduce inflammation and support cellular repair, which can help tissues recover and function more efficiently. While results vary, many patients describe noticeable improvements that positively affect their daily lives.
The Importance of Patient Evaluation Before Treatment
Before receiving therapy, patients must already have a diabetes diagnosis. At Stemedix, we do not perform diagnoses, imaging, or physical exams. Instead, the team reviews your existing medical records, including blood work, scans, and other test results, to develop a treatment plan tailored to your needs.
If your records are outdated, we can help gather updated information through a simple medical release form. This approach allows the team to design stem cell treatments in Saint Petersburg, FL, that are aligned with your current health profile and medical history, providing a personalized plan focused on your condition and goals.
Why Patients Choose Stemedix for Regenerative Medicine in Saint Petersburg, FL
Stem cell therapy can feel complex, and having a supportive team makes the process more approachable. Many patients look for guidance that balances professional expertise with personalized attention.
Personalized Treatment Planning Based on Medical Records
Each treatment plan is developed based on the patient’s individual medical background. You provide your medical records, including blood work, imaging, and prior test results, and our team reviews them carefully to create a tailored stem cell therapy plan that fits your specific health situation.
If any information is missing or outdated, our team helps gather updated records from your healthcare providers, making the process seamless. This coordination allows you to move forward with confidence, knowing your plan is based on complete and current medical information.
Dedicated Care Coordinators and Certified Providers
Every patient works with a dedicated Care Coordinator throughout their journey. Your coordinator is available to guide you through appointments, scheduling, and any questions that arise.
All treatments are carried out by board-certified providers who follow their accredited specialties. With their expertise, you receive safe, professional, and structured stem cell treatments while your Care Coordinator maintains clear communication at every step.
A Comfortable, Full-Service Patient Experience
We provide complete patient support. If you travel to Saint Petersburg, FL, the team helps arrange transportation, accommodations, and accessibility equipment such as wheelchairs, walkers, or shower chairs.
This comprehensive approach allows you to focus on your stem cell therapy without managing logistical details. Our team handles the planning, so your experience is as smooth and comfortable as possible.
What to Expect During the Stemedix Process
Going through your journey with stem cell therapy can feel unfamiliar, but knowing the steps ahead can help you feel more confident. Here is a clear picture of how the process unfolds and what you can expect at each stage.
Reviewing Medical History and Test Results
The process begins with a review of existing medical records. You will provide your current test results, imaging, and other relevant medical information so the team can carefully evaluate your condition. This review allows the specialists to tailor a treatment plan based on your personal health profile.
If any of your records are older than recommended, we can assist in obtaining updated tests or scans. This support makes the preparation smooth, letting you focus on the next steps of your therapy without added stress.
Coordinating Travel, Accommodations, and Accessibility Needs
Patients traveling to Saint Petersburg receive complete logistical support. You will find that scheduling transportation, booking accommodations, and arranging accessibility tools like wheelchairs or shower chairs is handled by our team.
This approach helps you arrive at appointments without worry, knowing that each detail of your travel and stay is organized for your comfort. From airport pick-up to daily visits, the process is structured so you can concentrate on your therapy sessions.
Continuous Care and Follow-Up Support
After therapy, we maintain communication with patients to support recovery and address any follow-up questions. You will continue working with your Care Coordinator, who serves as your main point of contact for guidance and any additional information you may need.
This ongoing communication helps you remain informed about your progress and next steps. We emphasize a patient-centered approach, making sure you feel supported through each phase of your stem cell treatments.
Take the Next Step in Your Diabetes Care Journey with Stemedix
Take the next step in exploring stem cell therapy for diabetes management with Stemedix. Our team offers personalized guidance, professional oversight, and full support throughout your treatment journey. You can request an information packet or speak directly with a Care Coordinator to learn more about stem cell therapy in Saint Petersburg, FL. Contact us today at (727) 456-8968 or yourjourney@stemedix.com, or visit our website to start your journey toward regenerative care.
Medical Review: Dr. Gerald Mastaw, MD – Board-Certified Physician Last Updated: October 2025
What Is Type 1 Diabetes?
Type 1 Diabetes (T1D) is a chronic autoimmune disease in which the immune system attacks the insulin-producing beta cells of the pancreas. Without enough insulin, glucose (blood sugar) cannot enter the body’s cells to produce energy, leading to elevated blood sugar levels and long-term health complications.
Common Symptoms Include:
Excessive thirst and frequent urination
Sudden, unintended weight loss
Persistent fatigue or low energy
Blurred vision
Slow-healing wounds or recurrent infections
Unlike Type 2 Diabetes, which can be influenced by lifestyle factors, Type 1 Diabetes is not caused by diet or inactivity and often appears in childhood or adolescence — though adults can develop it too.
Current Treatment Approaches
At present, there is no cure for Type 1 Diabetes. Standard care focuses on maintaining stable blood sugar levels and preventing complications.
Conventional Management Includes:
Insulin therapy: Daily injections or insulin-pump use.
Blood-glucose monitoring: Continuous glucose monitors (CGM) or finger-stick testing.
Nutrition and exercise planning: Balanced diet, carbohydrate counting, and regular activity.
Comprehensive medical support: Endocrinology follow-up, eye and kidney screening, and diabetes education.
While these methods are lifesaving, they do not address the underlying immune attack or regenerate lost beta cells, which is why regenerative medicine research is expanding rapidly in this field.
Regenerative Medicine & Stem Cell Therapy: A New Frontier
Regenerative medicine aims to repair or replace damaged tissue, offering a path toward restoring the body’s own insulin production. Stem cell research, including umbilical cord tissue-derived mesenchymal stem cells (UCT-MSCs) and stem cell-derived pancreatic islet cells, is showing measurable progress.
Potential Benefits Under Study
Stem cell-based therapies are being investigated for their ability to:
Replace or regenerate insulin-producing beta cells in the pancreas
Regulate immune activity to slow or stop autoimmune destruction
Restore natural insulin secretion and improve blood-sugar control
Reduce risk of long-term complications such as neuropathy or kidney damage
Among these, mesenchymal stem cells (MSCs) stand out for their anti-inflammatory and immunomodulatory properties, making them a promising supportive therapy alongside conventional care.
Note: Stem cell and islet-cell therapies for Type 1 Diabetes are currently investigational and not FDA-approved. Participation in clinical trials or specialized programs should always be discussed with qualified medical professionals.
Recent Clinical Studies on Regenerative Medicine for Type 1 Diabetes
2025 – Stem Cell-Derived Islets Restore Insulin Production
Title:Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes Journal:PubMed – Full Text Summary: A 2025 Phase 1/2 trial tested lab-grown pancreatic islet cells (therapy name: zimslecel, formerly VX-880) infused into the liver of people with T1D. After one year, all participants produced their own insulin, and 83% became insulin-independent by day 365. Average HbA₁c levels fell below 7%, and no severe hypoglycemia occurred. Researchers concluded that stem cell-derived islet therapy can safely restore insulin production and normalize blood-sugar control in T1D patients.
Title:Umbilical Cord-Derived Mesenchymal Stromal Cells Preserve Endogenous Insulin Production in Type 1 Diabetes Journal:Diabetologia (Springer) – Full Text Summary: In this Phase I/II double-blind trial (Sweden), adults with newly diagnosed T1D received a single infusion of allogeneic UCT-MSCs. After 12 months, the MSC group retained nearly all of their own insulin production (~10% decline), whereas the placebo group lost ~47%. Treated patients did not require higher insulin doses over the year, and no serious side effects occurred. Researchers concluded that UCT-MSC therapy is safe and may slow autoimmune beta-cell loss in early T1D.
2022 – Co-Transplantation Protects Against Complications
Title:Prevention of Chronic Diabetic Complications by Co-Transplantation of Umbilical Cord MSCs and Autologous Bone Marrow Journal:PubMed – Full Text Summary: Patients with long-standing T1D received a combination of donor UCT-MSCs plus their own bone-marrow cells. After 8 years, only 14% of treated patients developed nerve, kidney, or eye damage compared to 73% of controls. No safety issues were reported. The study suggested that co-transplantation significantly reduced long-term organ complications and may protect vascular and nerve health in T1D.
2021 – Repeat UCT-MSC Infusions Support Partial Remission
Title:Repeated Transplantation of Allogeneic Umbilical Cord MSCs in Type 1 Diabetes Journal:Stem Cell Research & Therapy – Full Text Summary: In this open-label controlled study, 27 patients received two IV UCT-MSC infusions (at baseline and 3 months). After one year, 40.7% of treated patients achieved clinical remission (increased insulin production) vs 11.5% of controls. Three patients became temporarily insulin-free for 3–12 months, while none in the control group did. No severe adverse events occurred, confirming the therapy’s favorable safety profile.
Could Stem Cell Therapy Be Right for You?
Stem cell-based approaches for Type 1 Diabetes may be worth exploring if you:
Were recently diagnosed and want to preserve remaining beta-cell function
Have long-standing T1D and seek new ways to reduce complications
Prefer a non-surgical, biologic approach aligned with ongoing medical care
Wish to learn about clinical research and future treatment possibilities
At Stemedix, our regenerative medicine team reviews each patient’s medical history, labs, and goals to see if biologic therapies might complement standard endocrine care. Our focus is on education, safety, and personalized treatment planning.
Medical Disclaimer
This information is for educational purposes only and does not replace medical advice. Stem cell and islet cell therapies for Type 1 Diabetes are investigational and not FDA-approved. Results vary between individuals. Always consult a qualified healthcare provider before pursuing new therapeutic options.
References
Pagliuca F. et al. Stem Cell-Derived Islets for Type 1 Diabetes.PubMed., 2025. Full Text
Korsgren O. et al. Umbilical Cord MSC Infusion Preserves Insulin Production in T1D.Diabetologia., 2023. Full Text
Hu J. et al. Co-Transplantation of UCT-MSCs and Bone Marrow Prevents Complications in T1D.PubMed., 2022. Full Text
Wang S. et al. Repeated Umbilical Cord MSC Infusions in Type 1 Diabetes.Stem Cell Res Ther., 2021. Full Text
Medical Review: Dr. Gerald Mastaw, MD – Board-Certified Physician Last Updated: October 2025
What Is Type 2 Diabetes?
Type 2 Diabetes (T2D) is a metabolic disorder in which the body becomes resistant to insulin, the hormone that moves glucose (sugar) from the bloodstream into cells for energy. Over time, the pancreas may also produce less insulin, leading to rising blood sugar and widespread cellular stress.
Common Symptoms Include:
Frequent urination and increased thirst
Fatigue or low energy
Blurred vision
Slow healing wounds or frequent infections
Tingling or numbness in hands or feet
T2D is often linked to genetic factors, diet, stress, and physical inactivity, but it can occur even in people of healthy weight. When blood sugar stays high for years, it can damage blood vessels, nerves, eyes, and kidneys, increasing risks of heart disease and neuropathy.
Current Treatment Options
Standard care focuses on keeping blood sugar within target range and reducing the risk of complications.
Oral medications: metformin, SGLT2 inhibitors, GLP-1 agonists, and others
Insulin therapy: added if oral drugs aren’t enough
Routine monitoring: blood pressure, cholesterol, and blood glucose control
Weight-management programs or bariatric surgery in select cases
These therapies can effectively manage symptoms and delay complications, but they don’t repair damaged cells or restore insulin sensitivity at a biologic level, which is where regenerative medicine comes in.
Regenerative Medicine & Metabolic Repair
Regenerative medicine is an emerging field that seeks to restore healthy cellular function rather than only manage symptoms. For Type 2 Diabetes and metabolic syndrome, the focus is on repairing insulin pathways, reducing inflammation, and supporting pancreatic and vascular health.
How Stem Cell and Biologic Therapies May Help
Research suggests that umbilical cord tissue-derived mesenchymal stem cells (UCT-MSCs) and related biologics can:
Reduce insulin resistance by lowering systemic inflammation and oxidative stress
Protect and repair pancreatic β-cells, helping them produce insulin more effectively
Enhance glucose uptake in muscle and liver cells for better energy use
Improve microcirculation to protect organs affected by diabetes
Support metabolic balance and fat-to-energy conversion
Note: Stem cell therapy for Type 2 Diabetes is not FDA-approved and is considered investigational. However, peer-reviewed studies show promising improvements in glucose control, insulin sensitivity, and organ function.
Recent Clinical Studies on Regenerative Therapies for Type 2 Diabetes
2024 – Umbilical Cord MSC Infusion Improves Glucose Control
Title:Allogeneic Umbilical Cord MSC Infusion for Type 2 Diabetes: A Phase II Randomized Trial Journal:Stem Cell Research & Therapy – Full Text Summary: Eighty adults with T2D received either standard care or two IV UCT-MSC infusions (1 month apart). At 12 months, the MSC group showed a mean HbA₁c reduction of 1.6%, improved C-peptide levels, and lower insulin resistance (HOMA-IR). No severe adverse events occurred. The authors concluded that UC-MSC therapy was safe and offered “clinically meaningful metabolic improvement.”
2022 – Stem Cell Co-Therapy Enhances Pancreatic Function
Title:Umbilical Cord MSC Transplantation Combined with Metformin Improves β-Cell Function in Type 2 Diabetes Journal:Frontiers in Endocrinology – Full Text Summary: Fifty patients with poorly controlled T2D were assigned to receive metformin alone or metformin plus IV UC-MSC infusions. After one year, the combination group showed higher C-peptide levels (indicating restored insulin production) and better blood-sugar control with fewer daily insulin requirements. No major side effects occurred. Researchers concluded that MSC therapy can synergize with standard drugs to enhance β-cell preservation.
2021 – Improved Organ Protection and Inflammation Reduction
Title:Systemic Infusion of UC-MSCs Reduces Inflammation and Improves Liver and Kidney Function in Diabetes Journal:Journal of Translational Medicine – Full Text Summary: In this multi-center study, patients with Type 2 Diabetes received a single dose of allogeneic UC-MSCs. Within 6 months, inflammatory markers (TNF-α, IL-6, CRP) fell by over 40%, and kidney and liver enzymes returned closer to normal ranges. Patients reported better energy levels and sleep quality. Investigators concluded that MSC therapy may help reduce systemic inflammation and protect organs affected by metabolic disease.
Could Regenerative Therapy Be Right for You?
You may wish to learn more about regenerative options if you:
Have Type 2 Diabetes that remains hard to control despite medications
Want to support long-term pancreatic and vascular health
Are interested in non-surgical, biologic approaches to improve metabolism
Seek to reduce future risks of neuropathy, retinopathy, or kidney damage
At Stemedix, our specialists use a personalized approach to evaluate whether cell-based therapy may complement standard diabetes care plans. Our goal is to support metabolic balance and overall well-being through evidence-informed biologic science.
Medical Disclaimer
This page is for educational purposes only and does not replace professional medical advice. Stem cell therapy for Type 2 Diabetes is investigational and not FDA-approved. Results vary by individual. Always consult a qualified healthcare provider before considering any new therapy.
References
Zhou J. et al. Allogeneic Umbilical Cord MSC Infusion for Type 2 Diabetes: Phase II Trial.Stem Cell Res Ther., 2024. Full Text
Liu S. et al. UC-MSC + Metformin Improve β-Cell Function in T2D.Front Endocrinol., 2022. Full Text
Chen H. et al. Systemic UC-MSC Infusion Reduces Inflammation and Improves Organ Function in Diabetes.J Transl Med., 2021. Full Text
According to the World Health Organization, an estimated 422 million people worldwide have diabetes. Numerous studies have demonstrated that people with diabetes are at an increased risk of developing both acute and chronic pancreatitis, which increases the risk of developing pancreatic cancer.
Considering the lack of effective therapeutic options for pancreatitis and the limited treatment options for diabetes, researchers have recently turned to the potential of using mesenchymal stem cells (MSCs) as alternative therapeutic treatment options for these conditions.
In this review, Scuteri and Monfrini evaluate the different uses of MSCs for both the treatment of diabetes and the reduction of diabetes-related disease development.
According to the authors, MSCs offer several advantages, including the ability to be isolated from different tissues in a simple way, the ability to be easily harvested and expanded in vitro, and the absence of ethical problems associated with harvesting and use.
In addition, MSCs demonstrate the ability to differentiate, release soluble factors, and migrate toward lesions and sites of inflammation. Considering that inflammation and apoptosis are significant etiopathological factors of diabetes and pancreatitis, Scuteri and Monfrini indicate that MSCs are excellent candidates for regenerative medicine purposes.
In the case of MSCs and diabetes, research has demonstrated that differentiation of MSCs into insulin-releasing cells has been demonstrated in vitro after direct contact with pancreatic islets; the release of anti-inflammatory and antioxidant factors has improved the engraftment and prolonged the survival of transplanted pancreatic islets; and inhibited the apoptotic pathways triggered by endoplasmic reticulum stress in transplanted pancreatic islets. In analyzing this research, the authors conclude that the potential exists for the safe and effective use of MSCs for treatment of diabetes.
Although there has been growing interest in exploring the potential of MSCs on pancreatitis, there have only been a few studies exploring this therapeutic option. In these studies, the presence of MSCs was observed to reduce fibrosis and parenchymal damage by reducing proinflammatory factor expression.
In regard to MSCs and pancreatic cancer, since diabetes and pancreatitis are risk factors for the development of pancreatic cancer and considering MSCs have been found to hold potential as a therapeutic option for these diseases, using MSCs to interrupt the flow of factors leading to the development of pancreatic cancer should lower the incidence of diabetes-related pancreatic cancers.
The authors conclude that MSCs are a very promising therapeutic option for the treatment of diabetes, pancreatitis, and pancreatic cancer.
Type 2 diabetes mellitus (T2DM) is a serious health condition characterized by progressive deterioration in glycemic control resulting from decreased insulin sensitivity and diminished insulin secretion. Currently, it is estimated that over 462 million people worldwide are affected by T2DM.
While diet, physical exercise, and glucose-lowering medications have been shown to improve hyperglycemia, the results have been temporary and have not been able to inhibit the pathogenesis or reduce the morbidity associated with this condition.
With the need for more effective approaches for the treatment of T2DM to be developed, Zang et al. conducted this single-center, randomized, double-blinded, placebo-controlled phase II trial study to explore the efficacy and safety of intravenous infusion of umbilical cord-derived mesenchymal stem cells (UC-MSCs) in Chinese patients with T2DM.
MSCs are a type of adult stem cell that exhibits profound anti-inflammatory and immunomodulator capacities. Considering the successful application of MSCs in a number of autoimmune diseases, including stroke, myocardial infarction, rheumatoid arthritis, and systemic lupus erythematosus, the authors hypothesized that MSC transplantation might also be a therapeutic option for the treatment of T2DM.
Specifically for this study, the authors randomly assigned 91 patients to receive intravenous infusion of UC-MSCs or placebo three times at 4-week intervals and followed up for 48 weeks over a period of three years.
The primary endpoint established for this study was the percentage of patients with glycated hemoglobin (HbA1c) levels of < 7.0% and daily insulin reduction of > 50% at 48 weeks; additional established endpoints included changes of metabolic control, insulin resistance, and safety.
At the end of the 48-week follow-up period, Zang et al. report that 20% of patients in the US-MSCs group and 4.55% reached the primary endpoint with the percentage of insulin reduction of the UC-MSCs group being significantly higher than that of the placebo group. The authors also reported that the glucose infusion rate (GIR) increased significantly in the UC-MSCs group while there was no significant observed change in the placebo group. There were also no major UC-MSC transplantation-related adverse events reported during this study.
While these results are promising, the authors point out that since the age, course of T2DM, condition of the islet β-cell function, and insulin resistance of the enrolled subjects were highly heterogeneous, the results of this study could not be extended to all patients with T2DM. The authors also call for additional long-term follow-up to validate their initial, short-term findings as well as for future well-controlled studies with an increased number of cases to better clarify the efficacy and safety of intravenous infusion of UC-MSCs for the treatment of T2DM.
The authors conclude this study by suggesting intravenous infusion of UC-MSCs administration is a safe and effective approach that could reduce exogenous insulin requirements alleviate insulin resistance and be a potential therapeutic option for patients with T2DM.
Source: Zang, L., Li, Y., Hao, H. et al. Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial. Stem Cell Res Ther 13, 180 (2022). https://doi.org/10.1186/s13287-022-02848-6
This website and its contents are not intended to treat, cure, diagnose, or prevent any disease. Stemedix, Inc. shall not be held liable for the medical claims made by patient testimonials or videos. They are not to be viewed as a guarantee for each individual. The efficacy for some products presented have not been confirmed by the Food and Drug Administration (FDA).
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Subscribe To Our Newsletter
Join our mailing list to receive the latest news and updates from our team.
You have Successfully Subscribed!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
Thanks for your interest!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
Thanks for your interest!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
Thanks for your interest!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
Thanks for your interest!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
Thanks for your interest!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
Thanks for your interest!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
Thanks for your interest!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
Thanks for your interest!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
Thanks for your interest!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
Thanks for your interest!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
Thanks for your interest!
Request Information Packet
We'll send your FREE information packet that outlines our entire personalized, stress-free stem cell treatment process!
St. Petersburg, Florida
